Subject
Genetics (clinical),Hematology,General Medicine
Reference26 articles.
1. Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII;Addiego;Lancet,1993
2. Safety and immunogenicity of recombinant factor VIII (Recombinate) in previously untreated patients (PUPs): a 7.3 year update. XXIII Congress of the WFH, the Hague;Gruppo;Haemophilia,1998
3. Recombinant FVIII (Kogenate) treatment of previously untreated patients (PUPs) with hemophilia A. Update of safety, efficacy and inhibitor development after seven study years. ISTH Florence;Lusher;Thromb Haemost,1997
4. Massive factor VIII infusion in hemophiliac with factor VIII inhibitor, high responder;Brackmann;Lancet,1977
5. Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose;Van Leeuwen;Br J Haemat,1986